Clinical trial
Disease Modification in Toxaemia of Pregnancy
NCT00175695 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00175695 |
|---|---|
| Title | Disease Modification in Toxaemia of Pregnancy |
| Official title | A Safety and Efficacy Trial of Recombinant Human Activated Protein C in Both Early-onset Pre-eclampsia and Severe Postpartum Pre-eclampsia. |
| Lead sponsor | University of British Columbia, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Pre-eclampsia |
| Intervention type | Drug |
| Interventions | Recombinant human activated protein C or drotrecogin alpha |
| Enrollment | 30 |
| Start date | Dec 1, 2004 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 4, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: